安阳微信上400块3小时-安阳微信上400块3小时_第1页

在临沧酒店晚上怎么叫服务

Welcome to the official website of Yantai Dongcheng Pharmaceutical Group Co., Ltd!
Stock Code: 002675
Strategic layout and planning of nuclear medicine
Your current position: home page >> Dongcheng nuclear medicine >>Strategic layout and planning of nuclear medicine

      1. Strategic layout of nuclear medicine

      Through strategic layout and merger and integration in the field of nuclear medicine, Dongcheng pharmaceutical has successively owned a radioactive drug production platform represented by Chengdu Yunke, a radioactive drug research and development platform represented by Shanghai Yitai, a radioactive drug instant labeling and distribution platform (nuclear pharmacy) represented by Shanghai Xinke, and a positron drug production and sales platform represented by Andico pharmaceutical Taiwan. Dongcheng pharmaceutical has become one of the few pharmaceutical enterprises with complete qualification and layout in the key links of nuclear medicine industry chain. At the same time, with the development of nuclear medicine, Dongcheng pharmaceutical has established a long-term cooperative relationship with excellent domestic and foreign industry and clinical experts, scientific research institutions, etc., which has strengthened the company's reserves in the future product development.

 

 

        2. Strategic planning of nuclear medicine

With radioactive drugs as the new core competitiveness of the enterprise, Dongcheng Pharmaceutical Co., Ltd. focuses on the company's advantageous resources, relies on the capital market to integrate the nuclear medicine industry at home and abroad. Through the strategic policy of "getting involved in the upstream, integrating the downstream and laying out the frontier", Dongcheng pharmaceutical has built an industrial platform of the whole value chain of the nuclear medicine industry.

Nuclear medicine is the strategic focus of Dongcheng pharmaceutical in the next 10 years. Dongcheng pharmaceutical will promote the development strategy of domestic and international markets at the same time.

On the domestic side, Dongcheng pharmaceutical will continue to integrate the relevant enterprises and products of domestic therapeutic / diagnostic radiopharmaceuticals, expand the clinical application of listed drugs, and expand the market scale of radioactive drugs

Internationally, Dongcheng pharmaceutical will fully implement the internationalization strategy, accelerate the pace of industrial investment, M & A and product layout. Accelerate the development of international pharmaceutical products and marketing team with the help of international leading experts and marketing teams, and promote the cooperation with international pharmaceutical companies and marketing teams.

 

contact us CONTACT US
0535-6391521
Switchboard: 86-535-6391521 / 6391522
Email: zxu @ midatlanticlegends.com
Address: No.7 Changbaishan Road, Yantai Development Zone, Shandong Province
Copyright 2014 Yantai Dongcheng Pharmaceutical Group Co., Ltd. All Rights Reserved Lu ICP Bei 18035060-1